nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—HTR6—Raloxifene—osteoporosis	0.146	0.221	CbGbCtD
Mianserin—HTR2B—Raloxifene—osteoporosis	0.13	0.197	CbGbCtD
Mianserin—CYP2B6—Raloxifene—osteoporosis	0.0526	0.0796	CbGbCtD
Mianserin—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0508	0.0769	CbGbCtD
Mianserin—CYP1A2—Estropipate—osteoporosis	0.0462	0.07	CbGbCtD
Mianserin—CYP2B6—Cholecalciferol—osteoporosis	0.0406	0.0615	CbGbCtD
Mianserin—CYP3A4—Estropipate—osteoporosis	0.0242	0.0367	CbGbCtD
Mianserin—CYP3A4—Calcitriol—osteoporosis	0.0242	0.0367	CbGbCtD
Mianserin—CYP1A2—Conjugated Estrogens—osteoporosis	0.0219	0.0331	CbGbCtD
Mianserin—CYP2D6—Cholecalciferol—osteoporosis	0.0196	0.0297	CbGbCtD
Mianserin—CYP3A4—Ergocalciferol—osteoporosis	0.0194	0.0293	CbGbCtD
Mianserin—CYP1A2—Estradiol—osteoporosis	0.0192	0.0291	CbGbCtD
Mianserin—CYP3A4—Raloxifene—osteoporosis	0.0162	0.0245	CbGbCtD
Mianserin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0156	0.0236	CbGbCtD
Mianserin—CYP3A4—Cholecalciferol—osteoporosis	0.0125	0.0189	CbGbCtD
Mianserin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0115	0.0173	CbGbCtD
Mianserin—CYP3A4—Estradiol—osteoporosis	0.0101	0.0152	CbGbCtD
Mianserin—Constipation—Etidronic acid—osteoporosis	0.000667	0.00305	CcSEcCtD
Mianserin—Eye disorder—Pamidronate—osteoporosis	0.000667	0.00305	CcSEcCtD
Mianserin—Bradycardia—Zoledronate—osteoporosis	0.000664	0.00303	CcSEcCtD
Mianserin—Cardiac disorder—Pamidronate—osteoporosis	0.000662	0.00303	CcSEcCtD
Mianserin—Nervous system disorder—Estropipate—osteoporosis	0.000662	0.00302	CcSEcCtD
Mianserin—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000661	0.00302	CcSEcCtD
Mianserin—Myalgia—Calcitriol—osteoporosis	0.000661	0.00302	CcSEcCtD
Mianserin—Dry mouth—Ibandronate—osteoporosis	0.00066	0.00302	CcSEcCtD
Mianserin—Mental disorder—Risedronate—osteoporosis	0.000658	0.003	CcSEcCtD
Mianserin—Breast disorder—Estradiol—osteoporosis	0.000656	0.003	CcSEcCtD
Mianserin—Skin disorder—Estropipate—osteoporosis	0.000656	0.00299	CcSEcCtD
Mianserin—Angiopathy—Pamidronate—osteoporosis	0.000648	0.00296	CcSEcCtD
Mianserin—Dry mouth—Calcitriol—osteoporosis	0.000646	0.00295	CcSEcCtD
Mianserin—Mediastinal disorder—Pamidronate—osteoporosis	0.000643	0.00294	CcSEcCtD
Mianserin—Shock—Raloxifene—osteoporosis	0.000643	0.00294	CcSEcCtD
Mianserin—Feeling abnormal—Etidronic acid—osteoporosis	0.000643	0.00294	CcSEcCtD
Mianserin—Nervous system disorder—Raloxifene—osteoporosis	0.000641	0.00293	CcSEcCtD
Mianserin—Connective tissue disorder—Zoledronate—osteoporosis	0.000641	0.00293	CcSEcCtD
Mianserin—Thrombocytopenia—Raloxifene—osteoporosis	0.00064	0.00292	CcSEcCtD
Mianserin—Shock—Ibandronate—osteoporosis	0.000637	0.00291	CcSEcCtD
Mianserin—Skin disorder—Raloxifene—osteoporosis	0.000635	0.0029	CcSEcCtD
Mianserin—Nervous system disorder—Ibandronate—osteoporosis	0.000635	0.0029	CcSEcCtD
Mianserin—Skin disorder—Ibandronate—osteoporosis	0.000629	0.00287	CcSEcCtD
Mianserin—Skin disorder—Calcitriol—osteoporosis	0.000615	0.00281	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000615	0.00281	CcSEcCtD
Mianserin—Eye disorder—Zoledronate—osteoporosis	0.000609	0.00278	CcSEcCtD
Mianserin—Paraesthesia—Estropipate—osteoporosis	0.000606	0.00277	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000606	0.00277	CcSEcCtD
Mianserin—Cardiac disorder—Zoledronate—osteoporosis	0.000605	0.00276	CcSEcCtD
Mianserin—Anaemia—Risedronate—osteoporosis	0.000604	0.00276	CcSEcCtD
Mianserin—Somnolence—Estropipate—osteoporosis	0.0006	0.00274	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000596	0.00272	CcSEcCtD
Mianserin—Angiopathy—Zoledronate—osteoporosis	0.000591	0.0027	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00059	0.00269	CcSEcCtD
Mianserin—Mediastinal disorder—Zoledronate—osteoporosis	0.000588	0.00268	CcSEcCtD
Mianserin—Vertigo—Risedronate—osteoporosis	0.000587	0.00268	CcSEcCtD
Mianserin—Eye disorder—Conjugated Estrogens—osteoporosis	0.000587	0.00268	CcSEcCtD
Mianserin—Syncope—Risedronate—osteoporosis	0.000586	0.00268	CcSEcCtD
Mianserin—Gastrointestinal disorder—Estropipate—osteoporosis	0.000583	0.00266	CcSEcCtD
Mianserin—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000583	0.00266	CcSEcCtD
Mianserin—Fatigue—Estropipate—osteoporosis	0.000582	0.00266	CcSEcCtD
Mianserin—Paraesthesia—Ibandronate—osteoporosis	0.000581	0.00265	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000577	0.00264	CcSEcCtD
Mianserin—Constipation—Estropipate—osteoporosis	0.000577	0.00264	CcSEcCtD
Mianserin—Loss of consciousness—Risedronate—osteoporosis	0.000574	0.00262	CcSEcCtD
Mianserin—Anaemia—Pamidronate—osteoporosis	0.000574	0.00262	CcSEcCtD
Mianserin—Weight increased—Estradiol—osteoporosis	0.000571	0.00261	CcSEcCtD
Mianserin—Mental disorder—Zoledronate—osteoporosis	0.000571	0.00261	CcSEcCtD
Mianserin—Agitation—Pamidronate—osteoporosis	0.000571	0.00261	CcSEcCtD
Mianserin—Angiopathy—Conjugated Estrogens—osteoporosis	0.00057	0.0026	CcSEcCtD
Mianserin—Constipation—Alendronate—osteoporosis	0.000568	0.0026	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000567	0.00259	CcSEcCtD
Mianserin—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000566	0.00258	CcSEcCtD
Mianserin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000564	0.00258	CcSEcCtD
Mianserin—Hypertension—Risedronate—osteoporosis	0.000564	0.00258	CcSEcCtD
Mianserin—Somnolence—Calcitriol—osteoporosis	0.000563	0.00257	CcSEcCtD
Mianserin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000559	0.00255	CcSEcCtD
Mianserin—Fatigue—Ibandronate—osteoporosis	0.000558	0.00255	CcSEcCtD
Mianserin—Syncope—Pamidronate—osteoporosis	0.000557	0.00254	CcSEcCtD
Mianserin—Arthralgia—Risedronate—osteoporosis	0.000556	0.00254	CcSEcCtD
Mianserin—Myalgia—Risedronate—osteoporosis	0.000556	0.00254	CcSEcCtD
Mianserin—Leukopenia—Pamidronate—osteoporosis	0.000556	0.00254	CcSEcCtD
Mianserin—Constipation—Ibandronate—osteoporosis	0.000553	0.00253	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000553	0.00252	CcSEcCtD
Mianserin—Pruritus—Etidronic acid—osteoporosis	0.000552	0.00252	CcSEcCtD
Mianserin—Mental disorder—Conjugated Estrogens—osteoporosis	0.00055	0.00251	CcSEcCtD
Mianserin—Feeling abnormal—Alendronate—osteoporosis	0.000548	0.0025	CcSEcCtD
Mianserin—Oedema—Ethinyl Estradiol—osteoporosis	0.000547	0.0025	CcSEcCtD
Mianserin—Loss of consciousness—Pamidronate—osteoporosis	0.000546	0.00249	CcSEcCtD
Mianserin—Jaundice—Estradiol—osteoporosis	0.000546	0.00249	CcSEcCtD
Mianserin—Dry mouth—Risedronate—osteoporosis	0.000544	0.00249	CcSEcCtD
Mianserin—Constipation—Calcitriol—osteoporosis	0.000542	0.00247	CcSEcCtD
Mianserin—Convulsion—Pamidronate—osteoporosis	0.000538	0.00246	CcSEcCtD
Mianserin—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000537	0.00245	CcSEcCtD
Mianserin—Hypertension—Pamidronate—osteoporosis	0.000536	0.00245	CcSEcCtD
Mianserin—Feeling abnormal—Ibandronate—osteoporosis	0.000533	0.00244	CcSEcCtD
Mianserin—Tremor—Zoledronate—osteoporosis	0.000532	0.00243	CcSEcCtD
Mianserin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000531	0.00243	CcSEcCtD
Mianserin—Hepatobiliary disease—Estradiol—osteoporosis	0.000529	0.00242	CcSEcCtD
Mianserin—Arthralgia—Pamidronate—osteoporosis	0.000529	0.00242	CcSEcCtD
Mianserin—Myalgia—Pamidronate—osteoporosis	0.000529	0.00242	CcSEcCtD
Mianserin—Shock—Risedronate—osteoporosis	0.000525	0.0024	CcSEcCtD
Mianserin—Anaemia—Zoledronate—osteoporosis	0.000525	0.0024	CcSEcCtD
Mianserin—Nervous system disorder—Risedronate—osteoporosis	0.000523	0.00239	CcSEcCtD
Mianserin—Agitation—Zoledronate—osteoporosis	0.000522	0.00238	CcSEcCtD
Mianserin—Skin disorder—Risedronate—osteoporosis	0.000518	0.00237	CcSEcCtD
Mianserin—Confusional state—Pamidronate—osteoporosis	0.000511	0.00234	CcSEcCtD
Mianserin—Vertigo—Zoledronate—osteoporosis	0.00051	0.00233	CcSEcCtD
Mianserin—Syncope—Zoledronate—osteoporosis	0.000509	0.00232	CcSEcCtD
Mianserin—Leukopenia—Zoledronate—osteoporosis	0.000508	0.00232	CcSEcCtD
Mianserin—Oedema—Pamidronate—osteoporosis	0.000507	0.00232	CcSEcCtD
Mianserin—Hepatitis—Estradiol—osteoporosis	0.000502	0.00229	CcSEcCtD
Mianserin—Shock—Pamidronate—osteoporosis	0.000499	0.00228	CcSEcCtD
Mianserin—Loss of consciousness—Zoledronate—osteoporosis	0.000499	0.00228	CcSEcCtD
Mianserin—Nervous system disorder—Pamidronate—osteoporosis	0.000497	0.00227	CcSEcCtD
Mianserin—Thrombocytopenia—Pamidronate—osteoporosis	0.000496	0.00227	CcSEcCtD
Mianserin—Tachycardia—Pamidronate—osteoporosis	0.000495	0.00226	CcSEcCtD
Mianserin—Connective tissue disorder—Estradiol—osteoporosis	0.000494	0.00225	CcSEcCtD
Mianserin—Rash—Etidronic acid—osteoporosis	0.000492	0.00225	CcSEcCtD
Mianserin—Convulsion—Zoledronate—osteoporosis	0.000492	0.00225	CcSEcCtD
Mianserin—Dermatitis—Etidronic acid—osteoporosis	0.000491	0.00224	CcSEcCtD
Mianserin—Vertigo—Conjugated Estrogens—osteoporosis	0.000491	0.00224	CcSEcCtD
Mianserin—Syncope—Conjugated Estrogens—osteoporosis	0.00049	0.00224	CcSEcCtD
Mianserin—Hypertension—Zoledronate—osteoporosis	0.00049	0.00224	CcSEcCtD
Mianserin—Headache—Etidronic acid—osteoporosis	0.000489	0.00223	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000486	0.00222	CcSEcCtD
Mianserin—Asthenia—Estropipate—osteoporosis	0.000484	0.00221	CcSEcCtD
Mianserin—Myalgia—Zoledronate—osteoporosis	0.000483	0.00221	CcSEcCtD
Mianserin—Arthralgia—Zoledronate—osteoporosis	0.000483	0.00221	CcSEcCtD
Mianserin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00048	0.00219	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00048	0.00219	CcSEcCtD
Mianserin—Paraesthesia—Risedronate—osteoporosis	0.000479	0.00219	CcSEcCtD
Mianserin—Pruritus—Estropipate—osteoporosis	0.000478	0.00218	CcSEcCtD
Mianserin—Asthenia—Alendronate—osteoporosis	0.000477	0.00218	CcSEcCtD
Mianserin—Hypotension—Pamidronate—osteoporosis	0.000474	0.00216	CcSEcCtD
Mianserin—Convulsion—Conjugated Estrogens—osteoporosis	0.000473	0.00216	CcSEcCtD
Mianserin—Dry mouth—Zoledronate—osteoporosis	0.000473	0.00216	CcSEcCtD
Mianserin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000472	0.00216	CcSEcCtD
Mianserin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000472	0.00215	CcSEcCtD
Mianserin—Pruritus—Alendronate—osteoporosis	0.00047	0.00215	CcSEcCtD
Mianserin—Eye disorder—Estradiol—osteoporosis	0.00047	0.00214	CcSEcCtD
Mianserin—Tinnitus—Estradiol—osteoporosis	0.000468	0.00214	CcSEcCtD
Mianserin—Constipation—Ethinyl Estradiol—osteoporosis	0.000468	0.00214	CcSEcCtD
Mianserin—Confusional state—Zoledronate—osteoporosis	0.000467	0.00213	CcSEcCtD
Mianserin—Cardiac disorder—Estradiol—osteoporosis	0.000466	0.00213	CcSEcCtD
Mianserin—Myalgia—Conjugated Estrogens—osteoporosis	0.000465	0.00212	CcSEcCtD
Mianserin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000465	0.00212	CcSEcCtD
Mianserin—Asthenia—Ibandronate—osteoporosis	0.000464	0.00212	CcSEcCtD
Mianserin—Oedema—Zoledronate—osteoporosis	0.000463	0.00212	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000462	0.00211	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000462	0.00211	CcSEcCtD
Mianserin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000461	0.0021	CcSEcCtD
Mianserin—Fatigue—Risedronate—osteoporosis	0.00046	0.0021	CcSEcCtD
Mianserin—Pruritus—Ibandronate—osteoporosis	0.000458	0.00209	CcSEcCtD
Mianserin—Constipation—Risedronate—osteoporosis	0.000456	0.00208	CcSEcCtD
Mianserin—Angiopathy—Estradiol—osteoporosis	0.000456	0.00208	CcSEcCtD
Mianserin—Shock—Zoledronate—osteoporosis	0.000456	0.00208	CcSEcCtD
Mianserin—Paraesthesia—Pamidronate—osteoporosis	0.000455	0.00208	CcSEcCtD
Mianserin—Asthenia—Calcitriol—osteoporosis	0.000455	0.00208	CcSEcCtD
Mianserin—Nervous system disorder—Zoledronate—osteoporosis	0.000454	0.00207	CcSEcCtD
Mianserin—Thrombocytopenia—Zoledronate—osteoporosis	0.000453	0.00207	CcSEcCtD
Mianserin—Mediastinal disorder—Estradiol—osteoporosis	0.000453	0.00207	CcSEcCtD
Mianserin—Tachycardia—Zoledronate—osteoporosis	0.000452	0.00206	CcSEcCtD
Mianserin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000451	0.00206	CcSEcCtD
Mianserin—Somnolence—Pamidronate—osteoporosis	0.000451	0.00206	CcSEcCtD
Mianserin—Skin disorder—Zoledronate—osteoporosis	0.00045	0.00205	CcSEcCtD
Mianserin—Pruritus—Calcitriol—osteoporosis	0.000448	0.00205	CcSEcCtD
Mianserin—Dizziness—Estropipate—osteoporosis	0.000446	0.00204	CcSEcCtD
Mianserin—Oedema—Conjugated Estrogens—osteoporosis	0.000446	0.00204	CcSEcCtD
Mianserin—Mental disorder—Estradiol—osteoporosis	0.00044	0.00201	CcSEcCtD
Mianserin—Dizziness—Alendronate—osteoporosis	0.00044	0.00201	CcSEcCtD
Mianserin—Shock—Conjugated Estrogens—osteoporosis	0.000439	0.002	CcSEcCtD
Mianserin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000438	0.002	CcSEcCtD
Mianserin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000437	0.002	CcSEcCtD
Mianserin—Fatigue—Pamidronate—osteoporosis	0.000437	0.002	CcSEcCtD
Mianserin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000435	0.00199	CcSEcCtD
Mianserin—Constipation—Pamidronate—osteoporosis	0.000434	0.00198	CcSEcCtD
Mianserin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000433	0.00198	CcSEcCtD
Mianserin—Hypotension—Zoledronate—osteoporosis	0.000433	0.00198	CcSEcCtD
Mianserin—Dizziness—Raloxifene—osteoporosis	0.000432	0.00197	CcSEcCtD
Mianserin—Dizziness—Ibandronate—osteoporosis	0.000428	0.00195	CcSEcCtD
Mianserin—Rash—Estropipate—osteoporosis	0.000426	0.00194	CcSEcCtD
Mianserin—Dermatitis—Estropipate—osteoporosis	0.000425	0.00194	CcSEcCtD
Mianserin—Headache—Estropipate—osteoporosis	0.000423	0.00193	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000422	0.00193	CcSEcCtD
Mianserin—Rash—Alendronate—osteoporosis	0.000419	0.00191	CcSEcCtD
Mianserin—Dermatitis—Alendronate—osteoporosis	0.000419	0.00191	CcSEcCtD
Mianserin—Feeling abnormal—Pamidronate—osteoporosis	0.000418	0.00191	CcSEcCtD
Mianserin—Hypotension—Conjugated Estrogens—osteoporosis	0.000417	0.0019	CcSEcCtD
Mianserin—Headache—Alendronate—osteoporosis	0.000416	0.0019	CcSEcCtD
Mianserin—Paraesthesia—Zoledronate—osteoporosis	0.000416	0.0019	CcSEcCtD
Mianserin—Rash—Raloxifene—osteoporosis	0.000412	0.00188	CcSEcCtD
Mianserin—Dermatitis—Raloxifene—osteoporosis	0.000412	0.00188	CcSEcCtD
Mianserin—Somnolence—Zoledronate—osteoporosis	0.000412	0.00188	CcSEcCtD
Mianserin—Tremor—Estradiol—osteoporosis	0.00041	0.00187	CcSEcCtD
Mianserin—Headache—Raloxifene—osteoporosis	0.00041	0.00187	CcSEcCtD
Mianserin—Rash—Ibandronate—osteoporosis	0.000408	0.00186	CcSEcCtD
Mianserin—Dermatitis—Ibandronate—osteoporosis	0.000408	0.00186	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000406	0.00186	CcSEcCtD
Mianserin—Headache—Ibandronate—osteoporosis	0.000405	0.00185	CcSEcCtD
Mianserin—Agitation—Estradiol—osteoporosis	0.000402	0.00184	CcSEcCtD
Mianserin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.0004	0.00183	CcSEcCtD
Mianserin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.0004	0.00183	CcSEcCtD
Mianserin—Rash—Calcitriol—osteoporosis	0.000399	0.00182	CcSEcCtD
Mianserin—Fatigue—Zoledronate—osteoporosis	0.000399	0.00182	CcSEcCtD
Mianserin—Dermatitis—Calcitriol—osteoporosis	0.000399	0.00182	CcSEcCtD
Mianserin—Headache—Calcitriol—osteoporosis	0.000397	0.00181	CcSEcCtD
Mianserin—Somnolence—Conjugated Estrogens—osteoporosis	0.000396	0.00181	CcSEcCtD
Mianserin—Constipation—Zoledronate—osteoporosis	0.000396	0.00181	CcSEcCtD
Mianserin—Vertigo—Estradiol—osteoporosis	0.000393	0.00179	CcSEcCtD
Mianserin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000393	0.00179	CcSEcCtD
Mianserin—Syncope—Estradiol—osteoporosis	0.000392	0.00179	CcSEcCtD
Mianserin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000387	0.00177	CcSEcCtD
Mianserin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000385	0.00176	CcSEcCtD
Mianserin—Fatigue—Conjugated Estrogens—osteoporosis	0.000385	0.00176	CcSEcCtD
Mianserin—Loss of consciousness—Estradiol—osteoporosis	0.000384	0.00176	CcSEcCtD
Mianserin—Asthenia—Risedronate—osteoporosis	0.000383	0.00175	CcSEcCtD
Mianserin—Feeling abnormal—Zoledronate—osteoporosis	0.000382	0.00174	CcSEcCtD
Mianserin—Constipation—Conjugated Estrogens—osteoporosis	0.000381	0.00174	CcSEcCtD
Mianserin—Hypertension—Estradiol—osteoporosis	0.000378	0.00172	CcSEcCtD
Mianserin—Pruritus—Risedronate—osteoporosis	0.000377	0.00172	CcSEcCtD
Mianserin—Arthralgia—Estradiol—osteoporosis	0.000372	0.0017	CcSEcCtD
Mianserin—Myalgia—Estradiol—osteoporosis	0.000372	0.0017	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00037	0.00169	CcSEcCtD
Mianserin—Dry mouth—Estradiol—osteoporosis	0.000364	0.00166	CcSEcCtD
Mianserin—Asthenia—Pamidronate—osteoporosis	0.000364	0.00166	CcSEcCtD
Mianserin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000362	0.00165	CcSEcCtD
Mianserin—Confusional state—Estradiol—osteoporosis	0.00036	0.00164	CcSEcCtD
Mianserin—Pruritus—Pamidronate—osteoporosis	0.000359	0.00164	CcSEcCtD
Mianserin—Oedema—Estradiol—osteoporosis	0.000357	0.00163	CcSEcCtD
Mianserin—Dizziness—Risedronate—osteoporosis	0.000353	0.00161	CcSEcCtD
Mianserin—Shock—Estradiol—osteoporosis	0.000351	0.0016	CcSEcCtD
Mianserin—Nervous system disorder—Estradiol—osteoporosis	0.00035	0.0016	CcSEcCtD
Mianserin—Tachycardia—Estradiol—osteoporosis	0.000348	0.00159	CcSEcCtD
Mianserin—Skin disorder—Estradiol—osteoporosis	0.000347	0.00158	CcSEcCtD
Mianserin—Rash—Ethinyl Estradiol—osteoporosis	0.000345	0.00158	CcSEcCtD
Mianserin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000345	0.00157	CcSEcCtD
Mianserin—Headache—Ethinyl Estradiol—osteoporosis	0.000343	0.00157	CcSEcCtD
Mianserin—Rash—Risedronate—osteoporosis	0.000336	0.00154	CcSEcCtD
Mianserin—Dermatitis—Risedronate—osteoporosis	0.000336	0.00153	CcSEcCtD
Mianserin—Dizziness—Pamidronate—osteoporosis	0.000335	0.00153	CcSEcCtD
Mianserin—Headache—Risedronate—osteoporosis	0.000334	0.00153	CcSEcCtD
Mianserin—Asthenia—Zoledronate—osteoporosis	0.000332	0.00152	CcSEcCtD
Mianserin—Pruritus—Zoledronate—osteoporosis	0.000328	0.0015	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000325	0.00149	CcSEcCtD
Mianserin—Paraesthesia—Estradiol—osteoporosis	0.000321	0.00146	CcSEcCtD
Mianserin—Asthenia—Conjugated Estrogens—osteoporosis	0.00032	0.00146	CcSEcCtD
Mianserin—Rash—Pamidronate—osteoporosis	0.00032	0.00146	CcSEcCtD
Mianserin—Dermatitis—Pamidronate—osteoporosis	0.000319	0.00146	CcSEcCtD
Mianserin—Headache—Pamidronate—osteoporosis	0.000318	0.00145	CcSEcCtD
Mianserin—Somnolence—Estradiol—osteoporosis	0.000317	0.00145	CcSEcCtD
Mianserin—Pruritus—Conjugated Estrogens—osteoporosis	0.000316	0.00144	CcSEcCtD
Mianserin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000308	0.00141	CcSEcCtD
Mianserin—Fatigue—Estradiol—osteoporosis	0.000308	0.00141	CcSEcCtD
Mianserin—Dizziness—Zoledronate—osteoporosis	0.000306	0.0014	CcSEcCtD
Mianserin—Constipation—Estradiol—osteoporosis	0.000305	0.00139	CcSEcCtD
Mianserin—Dizziness—Conjugated Estrogens—osteoporosis	0.000295	0.00135	CcSEcCtD
Mianserin—Feeling abnormal—Estradiol—osteoporosis	0.000294	0.00134	CcSEcCtD
Mianserin—Rash—Zoledronate—osteoporosis	0.000292	0.00133	CcSEcCtD
Mianserin—Dermatitis—Zoledronate—osteoporosis	0.000292	0.00133	CcSEcCtD
Mianserin—Headache—Zoledronate—osteoporosis	0.00029	0.00133	CcSEcCtD
Mianserin—Rash—Conjugated Estrogens—osteoporosis	0.000281	0.00128	CcSEcCtD
Mianserin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000281	0.00128	CcSEcCtD
Mianserin—Headache—Conjugated Estrogens—osteoporosis	0.000279	0.00128	CcSEcCtD
Mianserin—Asthenia—Estradiol—osteoporosis	0.000256	0.00117	CcSEcCtD
Mianserin—Pruritus—Estradiol—osteoporosis	0.000253	0.00115	CcSEcCtD
Mianserin—Dizziness—Estradiol—osteoporosis	0.000236	0.00108	CcSEcCtD
Mianserin—Rash—Estradiol—osteoporosis	0.000225	0.00103	CcSEcCtD
Mianserin—Dermatitis—Estradiol—osteoporosis	0.000225	0.00103	CcSEcCtD
Mianserin—Headache—Estradiol—osteoporosis	0.000224	0.00102	CcSEcCtD
Mianserin—CYP1A2—Metabolism—ACP5—osteoporosis	1.57e-05	0.000131	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	1.57e-05	0.000131	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—LEP—osteoporosis	1.57e-05	0.00013	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.57e-05	0.00013	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MGLL—osteoporosis	1.56e-05	0.00013	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.55e-05	0.000129	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—RAP1A—osteoporosis	1.55e-05	0.000129	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ADCY5—osteoporosis	1.55e-05	0.000129	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—LEP—osteoporosis	1.55e-05	0.000128	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—LEP—osteoporosis	1.55e-05	0.000128	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—GPX1—osteoporosis	1.54e-05	0.000128	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.54e-05	0.000128	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—LEP—osteoporosis	1.54e-05	0.000128	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—ADCY5—osteoporosis	1.53e-05	0.000127	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—IL6—osteoporosis	1.52e-05	0.000126	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KL—osteoporosis	1.5e-05	0.000125	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—ESR1—osteoporosis	1.5e-05	0.000124	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—SPP1—osteoporosis	1.48e-05	0.000123	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.48e-05	0.000123	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—ESR1—osteoporosis	1.48e-05	0.000123	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—ESR1—osteoporosis	1.48e-05	0.000123	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KL—osteoporosis	1.47e-05	0.000123	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KL—osteoporosis	1.47e-05	0.000122	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.47e-05	0.000122	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TPI1—osteoporosis	1.46e-05	0.000121	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—POMC—osteoporosis	1.46e-05	0.000121	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.44e-05	0.00012	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.44e-05	0.00012	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.44e-05	0.00012	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.44e-05	0.000119	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—POMC—osteoporosis	1.44e-05	0.000119	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.43e-05	0.000118	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—MTHFR—osteoporosis	1.42e-05	0.000118	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—LEP—osteoporosis	1.41e-05	0.000117	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.4e-05	0.000117	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.4e-05	0.000116	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IRS1—osteoporosis	1.4e-05	0.000116	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	1.39e-05	0.000115	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IRS1—osteoporosis	1.38e-05	0.000115	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IRS1—osteoporosis	1.38e-05	0.000115	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—P4HB—osteoporosis	1.37e-05	0.000114	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.37e-05	0.000114	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GAPDH—osteoporosis	1.35e-05	0.000112	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—POMC—osteoporosis	1.35e-05	0.000112	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.35e-05	0.000112	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IRS2—osteoporosis	1.34e-05	0.000112	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KL—osteoporosis	1.34e-05	0.000111	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.34e-05	0.000111	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.34e-05	0.000111	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.33e-05	0.000111	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—POMC—osteoporosis	1.33e-05	0.00011	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—POMC—osteoporosis	1.33e-05	0.00011	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—IDH2—osteoporosis	1.33e-05	0.00011	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—POMC—osteoporosis	1.32e-05	0.00011	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6R—osteoporosis	1.32e-05	0.000109	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.31e-05	0.000109	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—RAP1A—osteoporosis	1.31e-05	0.000109	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—LEP—osteoporosis	1.31e-05	0.000109	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.31e-05	0.000109	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IGF1—osteoporosis	1.3e-05	0.000108	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6R—osteoporosis	1.3e-05	0.000108	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6R—osteoporosis	1.29e-05	0.000108	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.29e-05	0.000107	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.29e-05	0.000107	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MYC—osteoporosis	1.29e-05	0.000107	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TGFB1—osteoporosis	1.29e-05	0.000107	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.29e-05	0.000107	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.29e-05	0.000107	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IGF1—osteoporosis	1.28e-05	0.000106	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IGF1—osteoporosis	1.28e-05	0.000106	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.28e-05	0.000106	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL6—osteoporosis	1.27e-05	0.000106	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.27e-05	0.000105	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.26e-05	0.000105	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ADCY5—osteoporosis	1.26e-05	0.000104	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—ESR1—osteoporosis	1.25e-05	0.000104	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ENO1—osteoporosis	1.25e-05	0.000104	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GPX1—osteoporosis	1.25e-05	0.000104	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.25e-05	0.000104	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.25e-05	0.000104	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PSMA2—osteoporosis	1.24e-05	0.000103	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PSMA5—osteoporosis	1.24e-05	0.000103	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ACP5—osteoporosis	1.21e-05	0.000101	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—POMC—osteoporosis	1.21e-05	0.000101	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.21e-05	0.000101	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MYC—osteoporosis	1.19e-05	9.9e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.19e-05	9.88e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.19e-05	9.85e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.18e-05	9.83e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ADCY5—osteoporosis	1.18e-05	9.79e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GPX1—osteoporosis	1.17e-05	9.76e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.17e-05	9.75e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IRS1—osteoporosis	1.17e-05	9.74e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.17e-05	9.72e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.17e-05	9.69e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.16e-05	9.67e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MTHFR—osteoporosis	1.16e-05	9.6e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.16e-05	9.6e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.15e-05	9.58e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.15e-05	9.52e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—LEP—osteoporosis	1.14e-05	9.51e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—LEP—osteoporosis	1.14e-05	9.46e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—POMC—osteoporosis	1.14e-05	9.46e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SPP1—osteoporosis	1.14e-05	9.44e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.13e-05	9.41e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.13e-05	9.41e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—POMC—osteoporosis	1.13e-05	9.38e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TPI1—osteoporosis	1.13e-05	9.37e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.12e-05	9.28e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SPP1—osteoporosis	1.12e-05	9.26e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.11e-05	9.2e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6R—osteoporosis	1.1e-05	9.15e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.09e-05	9.08e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.09e-05	9.03e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IGF1—osteoporosis	1.09e-05	9.02e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MTHFR—osteoporosis	1.08e-05	9e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ENO1—osteoporosis	1.06e-05	8.82e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—P4HB—osteoporosis	1.06e-05	8.81e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.06e-05	8.79e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.06e-05	8.79e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.05e-05	8.73e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PSMA2—osteoporosis	1.05e-05	8.7e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PSMA5—osteoporosis	1.05e-05	8.7e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GAPDH—osteoporosis	1.04e-05	8.65e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IRS2—osteoporosis	1.03e-05	8.53e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.02e-05	8.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.02e-05	8.46e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.02e-05	8.45e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.02e-05	8.44e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—RAP1A—osteoporosis	1.01e-05	8.43e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.01e-05	8.4e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IRS2—osteoporosis	1.01e-05	8.38e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—LEP—osteoporosis	1.01e-05	8.35e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP19A1—osteoporosis	1e-05	8.33e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MYC—osteoporosis	1e-05	8.32e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TGFB1—osteoporosis	9.99e-06	8.3e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6R—osteoporosis	9.94e-06	8.26e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—osteoporosis	9.92e-06	8.24e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—LEP—osteoporosis	9.89e-06	8.22e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IRS1—osteoporosis	9.88e-06	8.21e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—LEP—osteoporosis	9.87e-06	8.2e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—POMC—osteoporosis	9.84e-06	8.17e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IGF1—osteoporosis	9.8e-06	8.14e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—POMC—osteoporosis	9.79e-06	8.13e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—osteoporosis	9.77e-06	8.12e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—osteoporosis	9.76e-06	8.11e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—osteoporosis	9.71e-06	8.07e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—osteoporosis	9.7e-06	8.06e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ESR1—osteoporosis	9.6e-06	7.97e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.6e-06	7.97e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6R—osteoporosis	9.55e-06	7.93e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—POMC—osteoporosis	9.52e-06	7.91e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.46e-06	7.86e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ESR1—osteoporosis	9.44e-06	7.85e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ESR1—osteoporosis	9.42e-06	7.83e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IGF1—osteoporosis	9.41e-06	7.82e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6R—osteoporosis	9.28e-06	7.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—POMC—osteoporosis	9.25e-06	7.68e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IRS2—osteoporosis	9.2e-06	7.64e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IGF1—osteoporosis	9.16e-06	7.61e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—LEP—osteoporosis	9e-06	7.48e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IRS1—osteoporosis	8.97e-06	7.45e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—osteoporosis	8.96e-06	7.44e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—osteoporosis	8.92e-06	7.41e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.82e-06	7.33e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IRS1—osteoporosis	8.81e-06	7.31e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—POMC—osteoporosis	8.67e-06	7.2e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—POMC—osteoporosis	8.64e-06	7.17e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ESR1—osteoporosis	8.59e-06	7.14e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—POMC—osteoporosis	8.5e-06	7.06e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.49e-06	7.05e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—POMC—osteoporosis	8.48e-06	7.04e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6R—osteoporosis	8.42e-06	7e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IGF1—osteoporosis	8.31e-06	6.9e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—osteoporosis	8.3e-06	6.9e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6R—osteoporosis	8.29e-06	6.89e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6R—osteoporosis	8.27e-06	6.87e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ENO1—osteoporosis	8.2e-06	6.81e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ADCY5—osteoporosis	8.19e-06	6.8e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IGF1—osteoporosis	8.17e-06	6.79e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GPX1—osteoporosis	8.16e-06	6.78e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IGF1—osteoporosis	8.16e-06	6.78e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PSMA2—osteoporosis	8.08e-06	6.71e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PSMA5—osteoporosis	8.08e-06	6.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IRS1—osteoporosis	8.03e-06	6.67e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MYC—osteoporosis	7.79e-06	6.47e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TGFB1—osteoporosis	7.78e-06	6.46e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.73e-06	6.42e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MYC—osteoporosis	7.68e-06	6.38e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MYC—osteoporosis	7.67e-06	6.37e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TGFB1—osteoporosis	7.66e-06	6.37e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TGFB1—osteoporosis	7.65e-06	6.36e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MYC—osteoporosis	7.62e-06	6.33e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TGFB1—osteoporosis	7.6e-06	6.32e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6R—osteoporosis	7.54e-06	6.26e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—osteoporosis	7.53e-06	6.26e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—osteoporosis	7.53e-06	6.25e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—osteoporosis	7.5e-06	6.23e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IGF1—osteoporosis	7.44e-06	6.18e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.24e-06	6.01e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—osteoporosis	7.2e-06	5.98e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MYC—osteoporosis	7.01e-06	5.82e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—osteoporosis	7e-06	5.82e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TGFB1—osteoporosis	6.99e-06	5.81e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ADCY5—osteoporosis	6.94e-06	5.76e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GPX1—osteoporosis	6.91e-06	5.74e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.55e-06	5.44e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—osteoporosis	6.52e-06	5.42e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—osteoporosis	6.51e-06	5.41e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—osteoporosis	6.38e-06	5.3e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—osteoporosis	6.35e-06	5.28e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—osteoporosis	6.25e-06	5.19e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—osteoporosis	6.24e-06	5.18e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—POMC—osteoporosis	6.02e-06	5e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—osteoporosis	5.89e-06	4.89e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	5.88e-06	4.88e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—osteoporosis	5.86e-06	4.87e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—osteoporosis	5.77e-06	4.8e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—osteoporosis	5.77e-06	4.79e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—osteoporosis	5.73e-06	4.76e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.69e-06	4.72e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—osteoporosis	5.69e-06	4.72e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.67e-06	4.71e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—osteoporosis	5.66e-06	4.7e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.64e-06	4.69e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—osteoporosis	5.5e-06	4.57e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	5.49e-06	4.56e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ADCY5—osteoporosis	5.36e-06	4.45e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GPX1—osteoporosis	5.34e-06	4.43e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—osteoporosis	5.27e-06	4.38e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—POMC—osteoporosis	5.1e-06	4.24e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—osteoporosis	4.99e-06	4.15e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.98e-06	4.14e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—osteoporosis	4.93e-06	4.09e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—osteoporosis	4.91e-06	4.08e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—osteoporosis	4.9e-06	4.07e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—osteoporosis	4.9e-06	4.07e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.9e-06	4.07e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.89e-06	4.06e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.47e-06	3.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.46e-06	3.7e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—osteoporosis	4.43e-06	3.68e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—osteoporosis	4.27e-06	3.55e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—osteoporosis	4.25e-06	3.53e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—osteoporosis	4.14e-06	3.44e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—POMC—osteoporosis	3.94e-06	3.27e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—osteoporosis	3.75e-06	3.12e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—osteoporosis	3.69e-06	3.07e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—osteoporosis	3.68e-06	3.06e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.36e-06	2.79e-05	CbGpPWpGaD
